Survival advantage for mice with Friend Virus-induced erythroleukemia, by combination treatment of chronic low-dose chemotherapy and a selective COX-2 inhibitor

被引：0
|
作者：
Cervi, D [1 ]
Klement, G [1 ]
Koki, A [1 ]
Ben-David, Y [1 ]
机构：
[1] Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada
来源：
EXPERIMENTAL HEMATOLOGY | 2002年 / 30卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
214
引用
收藏
页码：90 / 90
页数：1
相关论文
共 12 条
  • [1] Inhibition of human Neuroblastoma in SCID mice by low-dose of selective Cox-2 inhibitor Nimesulide
    Bhupesh Parashar
    Bridget Shafit-Zagardo
    Journal of Neuro-Oncology, 2006, 78 : 129 - 134
  • [2] Inhibition of human Neuroblastoma in SCID mice by low-dose of selective Cox-2 inhibitor Nimesulide
    Parashar, Bhupesh
    Shafit-Zagardo, Bridget
    JOURNAL OF NEURO-ONCOLOGY, 2006, 78 (02) : 129 - 134
  • [3] Evidence of use: A selective COX-2 inhibitor in the treatment of experimental chronic pancreatitis induced by Dibutyltin dichloride
    Sukhodolya, Sergij
    Falalyeyeva, Tetyana
    Kuryk, Olena
    Petrushenko, Victoriya
    Beregova, Tetyana
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2015, 28 (02) : 131 - 135
  • [4] Proton pump inhibitor use in patients with indications for low-dose aspirin who start COX-2 selective inhibitors or nonselective NSAIDs
    Ofman, JJ
    Knight, K
    Badamgarav, E
    Henning, JM
    Wallace, K
    Wong, J
    Dylan, M
    Laine, L
    GASTROENTEROLOGY, 2003, 124 (04) : A107 - A107
  • [5] Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-Gamma Agonists in recurrent high-grade gliomas -: A phase II study
    Hau, P.
    Kunz-Schughart, L.
    Bogdahn, U.
    Baumgart, U.
    Hirschmann, B.
    Weimann, E.
    Muehleisen, H.
    Ruemmele, P.
    Steinbrecher, A.
    Reichle, A.
    ONCOLOGY, 2007, 73 (1-2) : 21 - 25
  • [6] Modeling and simulation to support dose selection and clinical development of SC-75416, a selective COX-2 inhibitor for the treatment of acute and chronic pain
    Kowalski, K. G.
    Olson, S.
    Remmers, A. E.
    Hutmacher, M. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (06) : 857 - 866
  • [7] Effect of low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza A virus-induced mortality in mice
    Nohara, K
    Izumi, H
    Tamura, S
    Nagata, R
    Tohyama, C
    TOXICOLOGY, 2002, 170 (1-2) : 131 - 138
  • [8] Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial
    Walter, I.
    Schulz, U.
    Vogelhuber, M.
    Wiedmann, K.
    Endlicher, E.
    Klebl, F.
    Andreesen, R.
    Herr, W.
    Ghibelli, L.
    Hackl, C.
    Wiest, R.
    Reichle, A.
    MEDICAL ONCOLOGY, 2017, 34 (12)
  • [9] Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial
    I. Walter
    U. Schulz
    M. Vogelhuber
    K. Wiedmann
    E. Endlicher
    F. Klebl
    R. Andreesen
    W. Herr
    L. Ghibelli
    C. Hackl
    R. Wiest
    A. Reichle
    Medical Oncology, 2017, 34
  • [10] Low-dose Aspirin, Non-steroidal Antiinflammatory Drugs, Selective COX-2 Inhibitor Prescriptions and Breast Cancer Recurrence: A Danish Population-based Cohort Study
    Cronin-Fenton, Deirdre
    Heide-Jorgensen, Uffe
    Ahern, Thomas P.
    Lash, Timothy L.
    Christiansen, Peer
    Ejlertsen, Bent
    Sorensen, Henrik T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 336 - 336
12